Ganglion-specific impairment of the norepinephrine transporter in the hypertensive rat

Hypertension

Volumn 61, Issue 1, 2013, Pages 187-193

  Shanks, Julia ^a   Mane, Saras ^a   Ryan, Rebecca ^a   Paterson, David J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

norepinephrine; norepinephrine reuptake transporter; spontaneously hypertensive rat; stellate; sympathetic

Indexed keywords

DESIPRAMINE; NORADRENALIN TRANSPORTER;

ADRENERGIC SYSTEM; ADRENERGIC TRANSMISSION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; ELECTRIC FIELD; ELECTROSTIMULATION; HEART NERVE; HYPERTENSION; KIDNEY INNERVATION; MALE; NERVE CELL MEMBRANE STEADY POTENTIAL; NONHUMAN; NORADRENALIN UPTAKE; PHENOTYPE; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE HEART FAILURE RAT; STELLATE GANGLION; SUPERIOR MESENTERIC GANGLIA; SYMPATHETIC NERVE CELL;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; CELLS, CULTURED; DESIPRAMINE; GANGLIA, SYMPATHETIC; HYPERTENSION; MALE; NEURONS; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; SYMPATHETIC NERVOUS SYSTEM; TYROSINE 3-MONOOXYGENASE;

EID: 84871614409     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.112.202184     Document Type: Article

References (40)

1. Anderson EA, Sinkey CA, Lawton WJ, Mark AL. Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings. Hypertension. 1989;14:177-183. (Pubitemid 19205172)
2. Greenwood JP, Stoker JB, Mary DA. Single-unit sympathetic discharge: quantitative assessment in human hypertensive disease. Circulation. 1999;100:1305-1310. (Pubitemid 29440123)
3. Schlaich MP, Lambert E, Kaye DM, Krozowski Z, Campbell DJ, Lambert G, Hastings J, Aggarwal A, Esler MD. Sympathetic augmentation in hypertension: role of nerve fring, norepinephrine reuptake, and Angiotensin neuromodulation. Hypertension. 2004;43:169-175. (Pubitemid 38174169)
4. Flaa A, Mundal HH, Eide I, Kjeldsen S, Rostrup M. Sympathetic activity and cardiovascular risk factors in young men in the low, normal, and high blood pressure ranges. Hypertension. 2006;47:396-402. (Pubitemid 43740281)
5. Lee RM, Triggle CR, Cheung DW, Coughlin MD. Structural and functional consequence of neonatal sympathectomy on the blood vessels of spontaneously hypertensive rats. Hypertension. 1987;10:328-338. (Pubitemid 17121907)
6. Cassis LA, Stitzel RE, Head RJ. Hypernoradrenergic innervation of the caudal artery of the spontaneously hypertensive rat: an infuence upon neuroeffector mechanisms. J Pharmacol Exp Ther. 1985;234:792-803. (Pubitemid 15240564)
7. Heaton DA, Li D, Almond SC, Dawson TA, Wang L, Channon KM, Paterson DJ. Gene transfer of neuronal nitric oxide synthase into intracar-diac Ganglia reverses vagal impairment in hypertensive rats. Hypertension. 2007;49:380-388. (Pubitemid 46143016)
8. Li D, Wang L, Lee CW, Dawson TA, Paterson DJ. Noradrenergic cell specifc gene transfer with neuronal nitric oxide synthase reduces cardiac sympathetic neurotransmission in hypertensive rats. Hypertension. 2007;50:69-74. (Pubitemid 46986012)
9. Li D, Lee CW, Buckler K, Parekh A, Herring N, Paterson DJ. Abnormal intracellular calcium homeostasis in sympathetic neurons from young pre-hypertensive rats. Hypertension. 2012;59:642-649.
10. Rumantir MS, Kaye DM, Jennings GL, Vaz M, Hastings JA, Esler MD. Phenotypic evidence of faulty neuronal norepinephrine reuptake in essential hypertension. Hypertension. 2000;36:824-829.
11. Zugck C, Lossnitzer D, Backs J, Kristen A, Kinscherf R, Haass M. Increased cardiac norepinephrine release in spontaneously hypertensive rats: role of presynaptic alpha-2A adrenoceptors. J Hypertens. 2003;21:1363-1369.
12. Rho JH, Newman B, Alexander N. Altered in vitro uptake of norepineph-rine by cardiovascular tissues of spontaneously hypertensive rats. Part 2. Portal-mesenteric veins and atria. Hypertension. 1981;3:710-717. (Pubitemid 12221899)
13. Mayer AF, Schroeder C, Heusser K, Tank J, Diedrich A, Schmieder RE, Luft FC, Jordan J. Infuences of norepinephrine transporter function on the distribution of sympathetic activity in humans. Hypertension. 2006;48:120-126. (Pubitemid 44297533)
14. Cabassi A, Vinci S, Quartieri F, Moschini L, Borghetti A. Norepinephrine reuptake is impaired in skeletal muscle of hypertensive rats in vivo. Hypertension. 2001;37(2 part 2):698-702. (Pubitemid 32199052)
15. Stephens N, Bund SJ, Jagger C, Heagerty AM. Arterial neuroeffec-tor responses in early and mature spontaneously hypertensive rats. Hypertension. 1991;18:674-682.
16. Rho JH, Newman B, Alexander N. Altered in vitro uptake of norepineph-rine by cardiovascular tissues of spontaneously hypertensive rats. Part 1. Mesenteric artery. Hypertension. 1981;3:704-709. (Pubitemid 12221898)
17. Kimura S, Miura Y, Adachi M, Adachi M, Nezu M, Toriyabe S, Sugawara T, Ishizuka Y, Noshiro T, Takahashi M. The effect of sodium depletion on plasma norepinephrine kinetics in patients with essential hypertension. Jpn Circ J. 1983;47:1232-1241. (Pubitemid 14247280)
18. Parker LK, Shanks JA, Kennard JA, Brain KL. Dynamic monitoring of NET activity in mature murine sympathetic terminals using a fuorescent substrate. Br J Pharmacol. 2010;159:797-807.
19. Bowers CW, Zigmond RE. Localization of neurons in the rat superior cervical ganglion that project into different postganglionic trunks. J Comp Neurol. 1979;185:381-391.
20. Berthoud HR, Powley TL. Characterization of vagal innervation to the rat celiac, suprarenal and mesenteric ganglia. J Auton Nerv Syst. 1993;42: 153-169.
21. Hamer DW, Santer RM. Anatomy and blood supply of the coeliac-superior mesenteric ganglion complex of the rat. Anat Embryol. 1981;162:353-362. (Pubitemid 11039544)
22. Wang L, Li D, Plested CP, Dawson T, Teschemacher AG, Paterson DJ. Noradrenergic neuron-specifc overexpression of nNOS in cardiac sympathetic nerves decreases neurotransmission. J Mol Cell Cardiol. 2006;41: 364-370. (Pubitemid 44080218)
23. He Y, Baas PW. Growing and working with peripheral neurons. Methods Cell Biol. 2003;71:17-35.
24. Axelrod J, Whitby LG, Hertting G. Effect of psychotropic drugs on the uptake of H3-norepinephrine by tissues. Science. 1961;133:383-384.
25. Esler M, Skews H, Leonard P, Jackman G, Bobik A, Korner P. Age-dependence of noradrenaline kinetics in normal subjects. Clin Sci. 1981;60:217-219. (Pubitemid 11119334)
26. Morrow LA, Linares OA, Hill TJ, Sanfeld JA, Supiano MA, Rosen SG, Halter JB. Age differences in the plasma clearance mechanisms for epinephrine and norepinephrine in humans. J Clin Endocrinol Metab. 1987;65:508-511. (Pubitemid 17131439)
27. Borton M, Docherty Jr. The effects of ageing on neuronal uptake of noradrenaline in the rat. Naunyn Schmiedebergs Arch Pharmacol. 1989;340:139-143. (Pubitemid 19203267)
28. Herring N, Lee CW, Sunderland N, Wright K, Paterson DJ. Pravastatin normalises peripheral cardiac sympathetic hyperactivity in the spontaneously hypertensive rat. J Mol Cell Cardiol. 2011;50:99-106.
29. Greenwood JP, Stoker JB, Mary DA. Single-unit sympathetic discharge: quantitative assessment in human hypertensive disease. Circulation. 1999;100: 1305-1310. (Pubitemid 29440123)
30. Nishimura M, Sato K, Shimada S, Tohyama M. Expression of norepi-nephrine and serotonin transporter mRNAs in the rat superior cervical ganglion. Brain Res Mol Brain Res. 1999;67:82-86. (Pubitemid 29170071)
31. Mandela P, Ordway GA. KCl stimulation increases norepinephrine transporter function in PC12 cells. J Neurochem. 2006;98:1521-1530. (Pubitemid 44202145)
32. Lopez Verrilli MA, Rodriguez Fermepín M, Longo Carbajosa N, Landa S, Cerrato BD, García S, Fernandez BE, Gironacci MM. Angiotensin-(1-7) through Mas receptor up-regulates neuronal nor-epinephrine transporter via Akt and Erk1/2-dependent pathways. J Neurochem. 2012;120:46-55.
33. Bönisch H, Brüss M. The noradrenaline transporter of the neuronal plasma membrane. Ann N Y Acad Sci. 1994;733:193-202.
34. Zahniser NR, Doolen S. Chronic and acute regulation of Na+/Cl-dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems. Pharmacol Ther. 2001;92:21-55. (Pubitemid 34032021)
35. Galli A, Blakely RD, DeFelice LJ. Patch-clamp and amperometric recordings from norepinephrine transporters: channel activity and voltage-dependent uptake. Proc Natl Acad Sci USA. 1998;95:13260-13265. (Pubitemid 28509559)
36. Apparsundaram S, Schroeter S, Giovanetti E, Blakely RD. Acute regulation of norepinephrine transport: II. PKC-modulated surface expression of human norepinephrine transporter proteins. J Pharmacol Exp Ther. 1998;287:744-751. (Pubitemid 29133678)
37. Apparsundaram S, Sung U, Price RD, Blakely RD. Traffcking-dependent and-independent pathways of neurotransmitter transporter regulation differentially involving p38 mitogen-activated protein kinase revealed in studies of insulin modulation of norepinephrine transport in SK-N-SH cells. J Pharmacol Exp Ther. 2001;299:666-677. (Pubitemid 32979681)
38. Sung U, Apparsundaram S, Galli A, Kahlig KM, Savchenko V, Schroeter S, Quick MW, Blakely RD. A regulated interaction of syntaxin 1A with the antidepressant-sensitive norepinephrine transporter establishes cat-echolamine clearance capacity. J Neurosci. 2003;23:1697-1709. (Pubitemid 36314725)
39. Sung U, Blakely RD. Calcium-dependent interactions of the human nor-epinephrine transporter with syntaxin 1A. Mol Cell Neurosci. 2007;34: 251-260. (Pubitemid 46137002)
40. Simms AE, Paton JF, Pickering AE, Allen AM. Amplifed respiratory- sympathetic coupling in the spontaneously hypertensive rat: does it contribute to hypertension? J Physiol (Lond). 2009;587(pt 3):597-610.